A Clinical-Stage Cancer Company Is Putting AI to Work at the Bench, Designing Its Next Generation of Tumor-Targeting DrugsPR Newswire·Jul 6 at 10:19 AMGTBP-2.88%
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga_article·Jun 1 at 07:06 AMGOVX-1.51%AIM+9.32%
EXCLUSIVE: GT Biopharma Sees Faster Discovery, Productivity Following AI Technology Rolloutbenzinga_article·Jun 1 at 06:31 AMGTBP-2.88%
The $13 Million Company Teaching the Immune System to Hunt CancerUnusual Whales·May 29 at 08:02 AMGTBP-2.88%SBIO+0.76%
B7-H3 Becomes The Hottest Antigen In Oncology, And One NK Engager Enters ClinicPR Newswire·May 18 at 01:22 PMGTBP-2.88%XBI+0.49%
Hot pre-market trades in US stocks: GT Biopharma pre-market down 8.93%; Everspin Tech pre-market down 8.86%Price Alert·May 15 at 04:17 AMGTBP-2.88%MRAM-5.74%
First Patient Dosed in Phase 1 Trial Marks Expansion of NK Cell Engager Platform Into Solid TumorsBaystreet·May 14 at 11:47 AMGTBP-2.88%SBIO+0.76%
